OncologyNews archives 2016

The ESMO OncologyPRO news, provided in partnership with medwireNews.


Date Title Topic
23 Dec 2016 Physician–Patient Communication Key For Appropriate Contralateral Prophylactic Mastectomy Decision Breast Cancer, Early Stage - Patient Education - Surgery and/or Radiotherapy of Cancer
22 Dec 2016 Vascular-Targeted Photodynamic Therapy ‘Effective’ For Low-Risk Prostate Cancer Prostate Cancer - Translational Research
21 Dec 2016 Genome-Adjusted Radiation Dosing Could Lead To Personalised Radiotherapy Translational Research - Surgery and/or Radiotherapy of Cancer
20 Dec 2016 Modified Neural Stem Cells Feasible For Local Delivery Of Chemotherapy To The Brain Anti-Cancer Agents & Biologic Therapy - Central Nervous System Malignancies - Translational Research
19 Dec 2016 Dual Targeted Molecular Therapy Fails To Improve Metastatic Pancreatic Cancer OS Anti-Cancer Agents & Biologic Therapy - Pancreatic Cancer
16 Dec 2016 METGastric, METLung Findings Add To Doubts On Onartuzumab Efficacy Anti-Cancer Agents & Biologic Therapy - Gastric Cancer - Non-Small-Cell Lung Cancer, Metastatic - Translational Research
15 Dec 2016 Accelerated RT Plus Panitumumab Fails To Improve PFS For Head And Neck SCC Anti-Cancer Agents & Biologic Therapy - Head and Neck Cancers - Surgery and/or Radiotherapy of Cancer
14 Dec 2016 Atezolizumab OS Benefit Shown For Stage IIIB–IV Previously Treated NSCLC Anti-Cancer Agents & Biologic Therapy - Cancer Immunology and Immunotherapy - Non-Small-Cell Lung Cancer, Metastatic
13 Dec 2016 High Stromal TILs Linked To Improved OS In Advanced HER2-Positive Breast Cancer Anti-Cancer Agents & Biologic Therapy - Breast Cancer, Metastatic - Cancer Immunology and Immunotherapy
12 Dec 2016 Acquired Clinically Actionable Alterations Common In Breast Cancer Brain Metastases Breast Cancer, Metastatic - Personalised Medicine
09 Dec 2016 Second-Line Regorafenib Boosts Advanced HCC Survival Anti-Cancer Agents & Biologic Therapy - Hepatobiliary Cancers
07 Dec 2016 Obinutuzumab Could Be ‘New Standard Of Care’ In Previously Untreated Follicular Lymphoma Anti-Cancer Agents & Biologic Therapy - Lymphomas
06 Dec 2016 Prophylactic ACE inhibitors, β-blockers Attenuate Trastuzumab-Mediated LVEF Decline Anti-Cancer Agents & Biologic Therapy - Breast Cancer, Early Stage - Complications of Treatment
05 Dec 2016 Alternating Pazopanib, Everolimus Not Supported In Metastatic Clear Cell RCC Anti-Cancer Agents & Biologic Therapy - Renal Cell Cancer
02 Dec 2016 Biosimilar Trastuzumab Shows ORR Equivalence For HER2-Positive Metastatic Breast Cancer Anti-Cancer Agents & Biologic Therapy - Drug Development - Bioethics, Legal, and Economic Issues - Breast Cancer, Metastatic